Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
CNOOC
00883
5
SINOPEC CORP
00386
| (FY)Dec 31, 2025 | (Q6)Jun 30, 2025 | (FY)Dec 31, 2024 | (Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | -19.34%12.32B | 9.56%6.94B | -38.73%15.28B | -23.11%6.33B | -6.32%24.93B | 63.90%8.23B | -21.55%26.61B | -62.65%5.02B | 0.57%33.93B | 32.61%13.45B |
| Operating income | -19.34%12.32B | 9.56%6.94B | -38.73%15.28B | -23.11%6.33B | -6.32%24.93B | 63.90%8.23B | -21.55%26.61B | -62.65%5.02B | 0.57%33.93B | 32.61%13.45B |
| Cost of sales | 16.29%-12.12B | -13.73%-6.22B | 35.25%-14.48B | 17.69%-5.47B | 0.68%-22.36B | -62.43%-6.65B | 11.56%-22.52B | 56.08%-4.09B | 0.11%-25.46B | -38.15%-9.32B |
| Operating expenses | 16.29%-12.12B | -13.73%-6.22B | 35.25%-14.48B | 17.69%-5.47B | 0.68%-22.36B | -62.43%-6.65B | 11.56%-22.52B | 56.08%-4.09B | 0.11%-25.46B | -38.15%-9.32B |
| Gross profit | -74.74%201.17M | -17.10%711.08M | -69.02%796.3M | -45.83%857.77M | -37.29%2.57B | 70.36%1.58B | -51.61%4.1B | -77.48%929.59M | 2.67%8.47B | 21.58%4.13B |
| Selling expenses | 25.88%-323.09M | 12.97%-160.46M | 33.94%-435.89M | 37.74%-184.36M | 22.93%-659.85M | 7.62%-296.11M | 19.07%-856.13M | 41.97%-320.54M | 15.58%-1.06B | -57.06%-552.37M |
| Administrative expenses | 26.05%-321.11M | 23.39%-132.6M | 12.76%-434.23M | 16.29%-173.09M | 19.85%-497.77M | 23.02%-206.76M | 34.88%-621.05M | 35.43%-268.6M | 15.81%-953.76M | 7.55%-415.99M |
| Profit from asset sales | ---- | ---- | 98.92%-2.04M | -104.67%-195K | ---188.02M | --4.18M | ---- | ---- | -67.74%15.83M | ---- |
| Revaluation surplus | 72.45%-231.73M | 49.05%-301.51M | 17.13%-841.24M | -52.06%-591.75M | -271.71%-1.02B | -2,624.94%-389.15M | -12,108.05%-273.09M | 82.93%-14.28M | -100.39%-2.24M | -155.66%-83.66M |
| -Changes in the fair value of investment property | 72.45%-231.73M | 49.05%-301.51M | 17.13%-841.24M | -52.06%-591.75M | -271.71%-1.02B | -2,624.94%-389.15M | -12,108.05%-273.09M | 82.93%-14.28M | -100.39%-2.24M | -155.66%-83.66M |
| Impairment and provision | -1,714.15%-168.95M | -625.85%-106.03M | 105.53%10.47M | 188.84%20.16M | -5,023.00%-189.44M | -83.13%6.98M | 101.54%3.85M | 278.07%41.38M | -952.27%-250.38M | 28.86%-23.24M |
| -Other impairment is provision | -1,714.15%-168.95M | -625.85%-106.03M | 105.53%10.47M | 188.84%20.16M | -5,023.00%-189.44M | -83.13%6.98M | 101.54%3.85M | 278.07%41.38M | -952.27%-250.38M | 28.86%-23.24M |
| Operating interest expense | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 16.70%-98.57M | 7.83%-254.77M | -18.79%-118.33M |
| Special items of operating profit | -87.50%-326.93M | -689.56%-119.11M | -8.44%-174.36M | 91.71%-15.09M | -126.34%-160.79M | -326.66%-182.01M | -136.78%-71.04M | 139.34%80.3M | -31.88%193.13M | 144.50%33.55M |
| Operating profit | -8.29%-1.17B | -25.52%-108.64M | -667.12%-1.08B | -116.62%-86.55M | -106.18%-140.92M | 49.09%520.73M | -62.97%2.28B | -88.23%349.27M | -4.85%6.16B | 17.03%2.97B |
| Financing income | -38.56%12.17M | -39.68%4.46M | 2.12%19.81M | -47.20%7.39M | -66.36%19.4M | --14M | --57.67M | ---- | ---- | ---- |
| Financing cost | -13.01%-405.33M | -25.57%-155.27M | -258.52%-358.68M | -73.38%-123.66M | 24.36%-100.04M | ---71.32M | ---132.26M | ---- | ---- | ---- |
| Share of profits of associates | 68.39%-25.88M | -266.00%-10.95M | -984.91%-81.9M | 42.69%-2.99M | -66.04%9.26M | -159.52%-5.22M | -78.62%27.25M | -103.53%-2.01M | 53.39%127.46M | 20.36%56.97M |
| Share of profit from joint venture company | 175.75%73.66M | 535.63%37.84M | 74.95%-97.24M | 272.20%5.95M | -1,174.57%-388.1M | -109.25%-3.46M | 2,086.26%36.12M | 1,744.84%37.36M | -99.70%1.65M | -94.38%2.03M |
| Earning before tax | 5.19%-1.52B | -16.37%-232.56M | -166.32%-1.6B | -143.95%-199.85M | -126.45%-600.41M | 18.23%454.73M | -63.90%2.27B | -87.29%384.62M | -11.43%6.29B | 13.43%3.03B |
| Tax | -44.20%-990.11M | 13.37%-260.35M | 41.25%-686.62M | 28.66%-300.52M | 21.53%-1.17B | -12.90%-421.24M | 61.36%-1.49B | 76.58%-373.09M | -5.87%-3.85B | -8.26%-1.59B |
| After-tax profit from continuing operations | -9.65%-2.51B | 1.49%-492.91M | -29.19%-2.29B | -1,593.72%-500.37M | -326.69%-1.77B | 190.48%33.5M | -67.93%780.45M | -99.20%11.53M | -29.64%2.43B | 19.78%1.43B |
| Earning after tax | -9.65%-2.51B | 1.49%-492.91M | -29.19%-2.29B | -1,593.72%-500.37M | -326.69%-1.77B | 190.48%33.5M | -67.93%780.45M | -99.20%11.53M | -29.64%2.43B | 19.78%1.43B |
| Minority profit | -10.52%-311.84M | 102.14%1.31M | -172.23%-282.17M | 32.76%-61.09M | -147.72%-103.65M | 32.22%-90.86M | -1.31%217.2M | -826.40%-134.05M | -72.64%220.09M | -107.47%-14.47M |
| Special items of profit attributable to shareholders | 9.43%98.54M | 1.10%44.01M | 4.30%90.05M | 2.55%43.53M | 4.85%86.34M | 6.87%42.45M | 40.28%82.34M | 81.26%39.72M | 26.14%58.7M | -7.64%21.91M |
| Profit attributable to shareholders | -9.52%-2.29B | -11.48%-538.23M | -19.50%-2.09B | -689.43%-482.8M | -464.29%-1.75B | -22.63%81.91M | -77.69%480.9M | -92.58%105.86M | -17.37%2.16B | 45.62%1.43B |
| Basic earnings per share | -9.21%-0.83 | -11.76%-0.19 | -20.63%-0.76 | -666.67%-0.17 | -470.59%-0.63 | -25.00%0.03 | -78.21%0.17 | -92.31%0.04 | -17.02%0.78 | 48.57%0.52 |
| Diluted earnings per share | ||||||||||
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS |
| Audit Opinions | -- | -- | -- | -- | -- | -- | Unqualified Opinion | -- | Unqualified Opinion | -- |
| Auditor | Daxin International (Hong Kong) Certified Public Accountants Limited | -- | Deloitte Touche Tohmatsu会计师事务所 | -- | Deloitte Touche Tohmatsu会计师事务所 | -- | Deloitte Touche Tohmatsu会计师事务所 | -- | Deloitte Touche Tohmatsu会计师事务所 | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.